BORGESON BLAKE sold 0.5% of their position (30K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $100.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/2/2026ACC: 0001601830-26-000103
Director
Since Apr 2021
-30K
Net shares
Net seller
$100.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−30K
Price / share
$3.34
Trade value
$100.20K
% of position
0.5%
9/1/2026
6.19M→6.16M
Total
Net shares
−30K
Net value
-$100.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/1/2026 | S · Sale | −30K | $3.34 | $100.20K | 0.5% | 6.19M | 6.16M |
| Total | −30K | -$100.20K | ||||||
Derivative Transactions0
No derivative transactions reported